CompletedPhase 2NCT00183092

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

Studying Acquired Creutzfeldt-Jakob disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of California, San Francisco
Principal Investigator: Michael Geschwind, MD, PhD
UCSF Memory & Aging Center, University of California, San Francisco
Intervention: Quinacrine(drug)
Enrollment: 69 enrolled
Eligibility: 18 years · All sexes
Timeline: 2005 – 2012

Study locations (1)

University of California, San Francisco, San Francisco, California, United States

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00183092 on ClinicalTrials.gov

← Back to all trials